Industry News
-
Retarglutide shows promising results in clinical trial, offering hope to Alzheimer’s patients
Retatrutide, a potential treatment for Alzheimer's disease, has made breakthrough progress in its latest clinical trial, showing promising results. This news brings hope to the millions of patients and their families affected by this devastating disease around the world....Read more -
Recent clinical study for Tirzepatide
In a recent phase 3 trial, Tirzepatide showed encouraging results in the treatment of type 2 diabetes. The drug was found to significantly lower blood sugar levels and promote weight loss in patients with the disease. Tirzepatide is a once-weekly injection that works by ...Read more -
Semaglutide effect for weight lose
A new study finds that the drug semaglutide can help people with type 2 diabetes lose weight and keep it off long-term. Semaglutide is a once-weekly injection drug that has been approved by the FDA to treat type 2 diabetes. The drug works by stimulating the release of in...Read more